Peyton R. Howell - 03 Aug 2023 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
Director
Signature
/s/ Rachel Malina, Attorney-in-Fact for Peyton R. Howell
Issuer symbol
TNDM
Transactions as of
03 Aug 2023
Net transactions value
$0
Form type
4
Filing time
07 Aug 2023, 17:16:35 UTC
Previous filing
26 May 2023
Next filing
24 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNDM Common Stock Options Exercise $0 +949 +8.4% $0.000000 12,256 03 Aug 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Restricted Stock Unit Options Exercise $0 -949 -100% $0.000000* 0 03 Aug 2023 Common Stock 949 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Awarded on August 3, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).
F2 Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.
F3 This RSU award was granted on August 3, 2020. 33% of the RSU vested on August 3, 2021 and the remaining shares will vest over a period of two years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan.